Meeting Web banner

ROCK Home ROCK Home Past & Future Meetings Past & Future Meetings

2024 Annual Meeting Program

Friday, January 26, 2024
10:00 - 12:00
Executive Committee Meeting
11:00
Registration Open
12:00 - 1:00
Industry Sponsored Lunch
Go Further. Help get to the root cause of early-onset or recurrent kidney stone disease with NovoDETECT™

Sponsored by Novo Nordisk Inc.
1:00 - 1:05
Welcome
1:05 - 2:00
Session I: Magnesium: Etiopathogensis To Treatment
Moderator:
Jody Lulich, University of Minnesota
1:05
Featured Lecture: Exploring the Role of Renal Magnesium Handling in Preventing Calcium Stone Formation
Ji Bin Peng
1:30
Magnesium citrate therapy increases urinary magnesium excretion in patients with urine magnesium
Emily C. Serrell
University of Wisconsin
1:40
Panel Discussion
1:50 - 3:00
Session II: From A Bacterial Perspective
Moderator:
Kristina Penniston, University of Wisconsin
1:50
Novel Antimicrobial Nanocomposites for Preventing Biofilm on Urologic Devices
Vijay Krishna
Cleveland Clinic
2:00
Pressure Bag Irrigation Associated with Increased Risk of Urinary Traction Infection Following Endoscopic Stone Surgery
Jackson Cabo
Vanderbilt University Medical Center
2:10
Culture-negative kidney stones harbor diverse bacteria and bacterial endotoxins
David T. Tzou
University of Arizona
2:20
Bacteria trigger calcium oxalate crystal formation
Kymora Scotland
UCLA
2:30
A unified model for microbial-induced urolithiasis
Aaron W. Miller
Cleveland Clinic
2:40
Panel Discussion
3:00 - 3:30
Break, visit posters and exhibits
3:30 - 4:40
Session III: Oxalate: Etiopathogenesis To Treatment
Moderator:
John Knight, University of Alabama at Birmingham
3:30
Gender Difference in Plasma and Urinary Oxalate Levels in a Mouse Model for Primary Hyperoxaluria Type 1
Hatim A. Hassan
Mayo Clinic
3:40
Metabolic Dysfunction-Associated Steatotic Liver Disease and Oxalate Synthesis
Kyle D. Wood
University of Alabama at Birmingham
3:50
The role of the gut microbiome and BUTyrate in calcium Oxalate kidney stone disease
Dirk Lange
The Stone Centre at VGH, University of British Columbia
4:00
Initial Oxalate Panel Discussion
4:10
Colonization with Oxalobacter formigenes and urinary oxalate excretion post Roux-en-Y bariatric surgery
Sonia Fargue
University of Alabama at Birmingham
4:20
Nedosiran in Patients with Primary Hyperoxaluria 3: Interim Results from an Open Label, Safety Extension Trial (PHYOX3)
David Goldfarb
Nephrology Division, NYU Langone Health
4:30
All Oxalate Panel Discussion
4:50 - 5:20
Session IV: Who Is Using Thiazides
Moderator:
David Goldfarb, New York Harbor VA Healthcare System
4:50
Make Thiazides Great Again: Strengthening the Evidence Base for Thiazides for Stone Prevention
Ryan Hsi
Vanderbilt University Medical Center
5:00
Effect of Hydrochlorothiazide (HCTZ) and Chlorthalidone (CTD) on 12 Hour versus 24 Hour Urinary Calcium Excretion
Daniel Wollin
Brigham and Women's Hospital
5:10
Panel Discussion
5:20 - 6:20
Poster Discussions And Networking Reception In Exhibit Hall

Saturday, January 27, 2024
7:30 - 8:00
Breakfast
8:00 - 9:00
Session V: Which Diagnostic Approach Is Best
Moderator:
John Asplin
8:00
“People send in teeth” and other things stone docs should know about stone analysis
Sara L. Best
University of Wisconsin - Madison
8:10
Intralaboratory and Interlaboratory Variability in the Analysis of 24-hour Urine Composition for Urinary Stone Prevention
Amy Reed
Vanderbilt University Medical Center
8:20
Prediction of kidney stone recurrence utilizing a joint modeling approach to analysis of 24-hour urine collections and multiple recurrent events
Brett A. Johnson
UT Southwestern
8:30
FGF23 and 24,25-Hydroxyvitamin D in Dent Disease
Carmen Reynolds
Mayo Clinic College of medicine and Science
8:40
Panel Discussion
9:00 - 10:00
Session VI: Rise Of The Machines
Moderator:
Megan Prochaska
9:00
“Rise of the Machines”: The Role of Artificial Intelligence in Kidney Stone Disease
Naveen Kachroo
Henry Ford Heatlh
9:10
Development of a Machine Learning (ML) Model to Automatically and Precisely identify Kidney Stones from Ureteroscopy Video recordings
Rajat Jain
University of Rochester Medical Center
9:20
Automated Analysis of Stone Dust During Ureteroscopy to Predict Stone Free Status Using Computer Vision Models
Nicholas Kavoussi
Vanderbilt University Medical Center
9:30
EMR data enhances prediction accuracy for care delays compared to standard demographic data
Sudarshan Srirangapatanam
University of Central Florida, College of Medicine, Orlando, FL
9:40
Panel Discussion
10:00 - 10:30
Break; Visit Posters and Exhibits
10:30 - 11:00
Session VII: Rise of The "Omics"
Moderator:
Eva Furrow, VMD, PhD, University of Minnesota
10:30
Clinical Characterization of a cohort with suspected monogenic stone disease
Ahmed R. Ali
Mayo Foundation for Medical Education and Research
10:40
Pilot analysis of the blood transcriptome in humans and dogs with spontaneous calcium oxalate kidney stones identifies pathway enrichment for interleukin signaling in both species
Lauren A. Baker
University of Wisconsin-Madison
10:50
Transcriptome and Proteome-wdie association studies reveal putative key molecules of kidney stone
Leting Zhou
Mayo Clinic
11:00
Panel Discussion
11:10 - 11:45
Session VIII: Implications Of Care And Cost
Moderator:
Andrew Rule, Mayo Clinic
11:10
Relationship between Patient Complexity, Rural-Urban Commuting Area Codes, and Surgeon Reimbursement: Ureteroscopy versus PCNL
Victoria S. Edmonds
Mayo Clinic Arizona
11:20
Neonatal Outcomes After Intervention for Suspected Renal Colic in Pregnancy
Smita De
Cleveland Clinic
11:30
Neighborhood Socioeconomic Disadvantage is Associated with Worse Urinary Risk Factors and Access to Medical Management for Urolithiasis
Amma Zampini
Cleveland Clinic
11:40
Panel Discussion
11:55 - 12:45
Industry Sponsored Lunch
“ImaJin®-ing” A More Efficient Laser and Improved Quality of Life Thulium Fiber Laser and Silicone Ureteral Stents

Sponsored by Coloplast
12:45 - 1:30
Annual Business Meeting
*ROCK Society members only
1:30 - 2:20
Session IX: Who Experiences The Most Pain
Moderator:
Vernon Pais, Dartmouth Hitchcock Medical Center
1:30
Trends in Opioid and Nonsteroidal Anti-inflammatory Drug Use for Patients with Kidney Stones in United States Emergency Departments
Ezra Margolin
Department of Urology, Duke University Medical Center
1:40
Unveiling Hidden Biases in Pain Management for Nephrolithiasis
Vishnu Ganesan
University of Minnesota
1:50
Characterizing pain location and intensity following ureteroscopy for stones-results from the USDRN Study to enhance understanding of stent associated symptoms
Jonathan Harper
University of Washington
2:00
Panel Discussion
2:20
Life Time Achievement Award: John Asplin
Presented by Jody Lulich
2:30 - 3:00
Break; Visit Posters and Exhibits
3:00
Featured Lecture: Establishing a kidney stone foundation
Josh Stern
Intermountain Health
3:10 - 4:00
Session X: Improving The Work Environment
Moderator:
Margaret Pearle, UT Southwestern
3:10
Risk of Occupational Hearing Loss During Common Endourologic Procedures: PCNL, URS, HoLEP, and SWL
Margaret Knoedler
University of Wisconsin
3:20
Feasibility and Acceptability of Shared Medical Appointments Utilizing Telehealth Medicine for Kidney Stone Prevention
Necole Streeper
Medical College of Wisconsin
3:30
Door To Stent Time: Timing Of Ureteral Stent Placement For Septic Urolithiasis
Patrick Lowry
Texas A&M College of Medicine/Baylor Scott and White
3:40
Panel Discussion
4:00 - 4:30
Session XI: Improving Patient Care
Moderator:
Vernon Pais, Dartmouth Hitchcock Medical Center
4:00
Assessment of the Optimal Settings of Thulium Fiber Laser for Laser Lithotripsy and Associated Thermal Injury Risk
Ezra Margolin
Department of Urology, Duke University Medical Center
4:10
Impact of residual stone fragments on risk of unplanned stone events following percutaneous nephrolithotomy.
Rajat Jain
University of Rochester Medical Center
4:20
Panel Discussion
4:15
Final Thoughts
4:30
Adjourn
6:00
Reception Dinner
No Transportation – 1.5 miles from Graduate Hotel
O'Shaughnessy Distilling Co., 600 Malcolm Ave SE, Minneapolis
Join your colleagues for a festive celebration capping off the annual meeting.

Posters
Urolith Etiopathogenesis and Treatment
Protein phosphorylation is diminished in calcium oxalate stone matrix and stone former urine proteins.
Jeffrey A. Wesson
Recessive variants in NEK1 and NEK8 are associated with cystic kidney and kidney stone disease.
Amar Majmundar
Long-term fructose and sucrose intake and the association with 24-hour urine composition
Megan Prochaska
Protein Intake Influences Risk of Uric Acid Stones
Hari Nair

Animal models for disease
Epidemiology and Structure of Osseous Stones in Cats and Dogs
Jody P. Lulich
Renal crystallopathy in Apoe-/- mice under oxalate diet: A potential model for nephrolithiasis
Jose Agudelo
Claudin-2 in renal calcification and intratubular plugs formation in mice
Muthuvel Jayachandran

Advancing Ureteroscopy & Lithotripsy
Current Practice Patterns of Laser Utilization in the Treatment of Urolithiasis
Eiftu S. Haile
Ureteroscopic Thulium versus Holmium Laser Stone Fragmentation for Renal and Ureteral Stones: A Cochrane Review
Jonathan Sussman
Impact of Integrated, Real-Time Digital Measurement on Surgeon Decision Making in Ureteroscopic Stone Surgery
Kevin Koo
Photonic Lithotripsy: A Novel Treatment Approach for Urolithiasis
Vijay Krishna
In-Vitro Comparison of a Novel Recessed Tip versus Standard Tip Fiber for Stone Dusting with Thulium Fiber Laser
Cyrus Chehroudi
To Bego or not to Bego: Updating Kidney Stone Phantoms
Stephen J. Hassig
Does Percutaneous Nephrolithomy Impact Renal Parenchymal Volume and Function?
Eiftu Hailee

Improving outcomes for patients with Comorbidities
Early signs of insulin resistance in kidney stone patients
Megan Prochaska
Impact of Diabetic Treatment on 24-Hour Urine Studies in Patients with Diabetes and Nephrolithiasis
David Schulsinger
Obesity associated with worse stone-related quality of life: lowest scores in class 3 (BMI >40) stone patients
Ali Antar
Sarcopenia is Highly Prevalent but not Associated with Worse Peri-Operative Outcomes in Elderly Patients Following Percutaneous Nephrolithotomy
Cyrus Chehroudi
Evaluating the Incidence of Nephrolithiasis Surgery Before and After Parathyroid Surgery: A Retrospective Observational Study
Scott Quarrier
Etiology, Natural History and Incidence of Kidney Stone Events in a Cohort of Patients with Enteric Hyperoxaluria
Stephen O’Neil

Improving Care Delivery
EMR data enhances prediction accuracy for care delays compared to standard demographic data
David Bayne
Relationship between Ureteral Stent Symptom Questionnaire (USSQ) and preference-based (health utility) measures of quality of life in patients with indwelling ureteral stents
Ephrem O. Olweny
Claims-based approach to defining episodes of care associated with acute renal colic
David F. Friedlander
Patient Belief in Effectiveness of Alkali Therapy for Stone Prevention is Higher than Thiazide, though Adherence is Lower
Shuhei Hirano
People with Kidney Stones Have Narrow Knowledge of Kidney Stone Nutrition
Melanie Betz

Improving the Work Environment
Association of Rotating Night Shift Work with Kidney Stone Risk in the Nurses’ Health Studies
Joseph J. Crivelli
MyUrology Health: Implementation of a Novel Episode Based Payment Model for Nephrolithiasis
Kate Dwyer
Evaluating the feasibility of ChatGPT in responding to electronic patient-provider communication
Deepak K. Agarwal

Oxalate: Etiopathogenesis To Treatment
Oxalate metabolism redundancy is responsible for response to dietary oxalate consumption in humans
Mangesh Suryavanshi
Oxalate induces colitis through MyD88-specific inflammatory pathways, dependent on the gut microbiota.
Sromona Mukherjee